CD133(+) Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense. Yu NN, Liu Y, Guo XY, Kim KK, et al. Anticancer Res 2026;46:1293-1306.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu NN, Liu Y, Guo XY, Kim KK, et al. CD133(+) Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense. Anticancer Res 2026;46:1293-1306.
PMID: 41760234